NCT02568553 2025-11-26Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1 Completed35 enrolled
NCT01741792 2017-01-06Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)Amgen Research (Munich) GmbHPhase 2 Completed25 enrolled 18 charts